The annual renewal of federal funding for Title X, a program providing reproductive health services, is slated for April 1, but health clinics nationwide are bracing for potential delays after the Health and Human Services Department (HHS) drastically shortened the grant application window this year.
For clinics relying on Title X funds – totaling over $286 million in 2023 – the uncertainty threatens access to care for more than 2.8 million individuals, many of whom are low-income or uninsured. The program supports a range of services including birth control, cancer screenings, HIV testing, and wellness exams.
Typically, the application process opens in the fall, allowing clinics months to prepare their requests. This year, however, HHS began accepting applications on March 13, granting clinics just one week to submit their proposals. Clinics were instructed to exhaust last year’s awards by Tuesday, with the possibility of requesting permission to roll over unused funds.
“I’ve never, ever, ever seen such a short turnaround between applications being due and the funding deadline,” said Clare Coleman, CEO of the National Family Planning and Reproductive Health Association, an advocacy group representing Title X clinics. As of Tuesday afternoon, Coleman reported that none of the clinics she represents had received confirmation of their grant awards.
The standard review period for Title X applications typically spans 70 to 90 days, according to Coleman. HHS spokesperson Andrew Nixon declined to address whether funds would be distributed on schedule, instead providing a statement regarding the fiscal year 2027 Notice of Funding Opportunity (NOFO) process.
“HHS, through the Office of the Assistant Secretary for Health, will issue novel fiscal year 2027 Notices of Funding Opportunity (NOFOs) for the Title X program matched with agency priorities,” Nixon stated.
Clinics are likewise awaiting clarification on whether HHS will reimburse expenses incurred during the potential funding gap. Nixon did not respond to a query regarding potential reimbursements.
Enacted in 1970 under President Richard Nixon, Title X aimed to reduce unintended pregnancies by providing accessible contraception. Over time, the program expanded to encompass a broader spectrum of reproductive health services, including fertility care, cancer screenings, and STI testing, and treatment.
Services are offered on a sliding fee scale, with individuals earning 100% of the federal poverty level or less – approximately $33,000 for a family of four – qualifying for free care. Federal law mandates that clinics receiving Title X funding cannot deny services to patients based on their ability to pay.
Brian Haile, CEO of Neighborhood Health, a network of 12 clinics in the Nashville, Tennessee area, is developing contingency plans assuming funding will not arrive this week. “What we’re trying to figure out is how much can we dip into our savings account to pay for expenses in hopes that we get reimbursed,” Haile said.
Neighborhood Health primarily serves communities of color and low-income individuals. Haile noted an increase in demand for Title X services this year, coinciding with rising insurance premiums that have prompted some individuals to discontinue their Affordable Care Act coverage.
A lack of funding could force Neighborhood Health to implement temporary cuts, potentially including payroll reductions or the introduction of small fees for services like insulin, which are currently provided at no cost.
“April 1 is going to be a really cruel April Fools’,” Haile said.
Planned Parenthood North Central States, operating clinics across five states, intends to maintain its sliding scale fees for as long as possible, according to President and CEO Ruth Richardson. “We would be continuing to honor that Title X sliding scale fee for at least the next month or so and then having to kind of re-evaluate” if funding remains delayed, Richardson said.
Prior to the opening of applications this month, Senate Democrats urged HHS Secretary Robert F. Kennedy Jr. In a letter to ensure timely funding, warning of “catastrophic” health consequences. A subsequent letter from a coalition of Democratic governors emphasized the importance of meeting the April 1 deadline.
Funding disruptions are not unprecedented. Last year, the Trump administration temporarily froze approximately a quarter of Title X grants, impacting an estimated 842,000 patients. The grants were restored in December following a lawsuit filed by the National Family Planning and Reproductive Health Association, which was voluntarily dismissed in January.
President Trump’s 2026 budget proposal sought to eliminate all funding for Title X, but Congress ultimately included the program in the enacted funding bill.
“These are all essential health care services that people need,” Richardson said. “This proves much more cost-effective to invest proactively in the Title X program than to pay the cost of the downstream consequences.”
The current five-year grants awarded in 2022 are nearing their expiration, requiring clinics to reapply annually for funding.
During the Trump administration, a rule barring Title X clinics from providing abortion care or referrals led roughly 1,000 clinics to withdraw from the program. The Biden administration reversed these regulations, and the current administration has not reinstated them.
“The Title X program, at least for the last decade, has been targeted politically in many ways,” Coleman said. “It has not received an increase in its annual congressional funding for 11 straight fiscal years. There have been repeated attempts by members of Congress to eliminate the program entirely.”
Nevertheless, Coleman remains optimistic. “The program survives, and we believe the program will continue to survive.”
